Acadia Healthcare Company, Inc. (ACHC)
David Einhorn signals caution as his hedge fund Greenlight prioritizes capital protection
Greenlight Capital's David Einhorn warned that investors may be underestimating potential downside risks. "It probably won't surprise anyone that we are again putting capital preservation at the top of our priorities," Einhorn said in his latest investor letter.
4 Stocks to Watch in a Rapidly Transforming Hospital Industry
The Zacks Medical-Hospital industry is evolving as demand rises, care shifts beyond hospitals, and consolidation picks up. Tenet Healthcare, Universal Health, Acadia and Community Health stand out.
Evaluating Acadia Healthcare's Outlook: Hold for Now or Fold?
ACHC rides on strong demand and expansion gains, but premium valuation, rising costs, and weak efficiency raise caution for investors weighing next moves.
Why Is Acadia Healthcare (ACHC) Up 7% Since Last Earnings Report?
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?
Abrams Bison Investments LLC Acquires 800,000 Shares of Acadia Healthcare Company, Inc. $ACHC
Abrams Bison Investments LLC lifted its holdings in Acadia Healthcare Company, Inc. (NASDAQ: ACHC) by 22.3% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 4,380,000 shares of the company's stock after purchasing an additional 800,000 shares during the quarter. Acadia Healthcare comprises 8.5% of
Acadia Healthcare Company, Inc. (ACHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Acadia Healthcare Company, Inc. (ACHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Acadia Healthcare Company, Inc. (ACHC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Acadia Healthcare Company, Inc. (ACHC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Acadia Healthcare Company, Inc. (ACHC) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Acadia Healthcare Company, Inc. (ACHC) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Acadia Healthcare: New Management Deserves A Shot At Turning Business Around
Acadia Healthcare Company, Inc. maintains a Buy rating as new CEO Debbie Osteen focuses on operational stability and disciplined capital allocation amid ongoing industry headwinds. ACHC 2025 revenues reached $3.3bn with adjusted EBITDA of $609m, but a net loss of $1.1bn was driven by a non-cash goodwill impairment. 2026 guidance projects modest revenue growth to $3.37–$3.45bn, adjusted EBITDA of $575–$610m, and EPS decline, reflecting a reset year with limited organic volume growth.
Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings Call Transcript
Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings Call Transcript
Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions
ACHC tops Q4 estimates as admissions and patient days rise, lifting revenues, but profit plunges 89% year over year.
Acadia Healthcare (ACHC) Surpasses Q4 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.64 per share a year ago.
